Filter by
 

Publication date

Series/ Type

Series/type

Language

Main subject

Main subject

Keywords

Keywords

Publications database

Displaying 1 - 10 of 10

Manuals and guidelines

How to run a trends workshop: An EMCDDA foresight toolkit for the drugs field

June 2022

This toolkit aims to support the EMCDDA’s stakeholders, other actors and researchers in the drugs field to implement their own foresight exercise in the form of an introductory trend-based workshop. It describes briefly the foresight and trend analysis approach and general principles of how both...

Manuals and guidelines

EMCDDA guide to holding a stakeholder round-table on supporting hepatitis C testing and care in drug services

July 2021

This guide is aimed at supporting teams organising stakeholder round-table meetings as part of their regional or national diagnostic processes aimed at identifying barriers to and opportunities to increase hepatitis C virus  testing and care in drug services.

Manuals and guidelines

EMCDDA operating guidelines for the risk assessment of new psychoactive substances

December 2020

The purpose of these guidelines is to ensure compliance with the scope and requirements of Regulation (EC) No 1920/2006 (as amended) and Council Framework Decision 2004/757/JHA (as amended) in respect to the risk assessment procedure for and reporting on new psychoactive substances. To...

Manuals and guidelines

Communicating results of wastewater-based epidemiology applied to illicit drugs: the do’s and don’ts

March 2020

Wastewater-based epidemiology (WBE) is a rapidly developing scientific discipline with potential for monitoring real-time data on geographical and temporal trends in illicit drug use, which established itself as a useful complement to existing monitoring tools in the illicit drugs area....

Manuals and guidelines

EMCDDA operating guidelines for the European Union Early Warning System on new psychoactive substances

December 2019

These guidelines provide the rationale, steps, procedures, roles, and responsibilities for the operation of the EU Early Warning System. They reflect the requirements of Regulation (EC) No 1920/2006 (as amended) and Council Framework Decision 2004/757/JHA (as amended) with respect to information...

Manuals and guidelines

Financial regulation of the European Monitoring Centre for Drugs and Drug Addiction (EMCDDA)

June 2019

This regulation lays down the essential financial rules for the European Monitoring Centre for Drugs and Drug Addiction (EMCDDA). It is based on and does not depart from the Commission Delegated Regulation (EU) 2019/715 of 18 December 2018 on the framework financial regulation for the bodies set...

Manuals and guidelines

Drug-related infectious diseases (DRID) toolkit

November 2013

The toolkit is designed to help health professionals improve their monitoring practice in order to reduce the burden of disease in this vulnerable group and improve the coverage and quality of services delivered. Prepared closely with experts, country representatives and international and EU...

Manuals and guidelines

Risk assessment of new psychoactive substances — operating guidelines

March 2010

The principal aim of these guidelines is to put in place a sound methodological and procedural basis for carrying out each risk assessment, by using a semi-quantitative assessment procedure. This publication is a revision of the Guidelines for the risk assessment of new synthetic drugs (published...

Manuals and guidelines

Early-warning system on new psychoactive substances — operating guidelines

October 2007

These practical guidelines have been published to assist the implementation of the Council decision on information exchange, risk-assessment and control of new psychoactive substances. They deal with phase 1 of the measures foreseen — the early-warning system.

Manuals and guidelines

Guidelines for the risk assessment of new synthetic drugs

August 1999

This publication was drawn up by the steering group created by the EMCDDA's Scientific Committee in November 1998 to establish guidelines to assess the risks of all new synthetic drugs identified under the terms of the Joint Action concerning the information exchange, risk assessment and control of...
Loading